NCT00003183 Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00003162 Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003124 Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003115 Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy Status COMPLETED Phase PHASE3
NCT00003104 Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003084 Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003045 Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer Status COMPLETED Phase NA
NCT00003038 Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00003026 Hormone Therapy in Treating Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE3
NCT00002924 Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy Status COMPLETED Phase N/A
NCT00002889 Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00002881 Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00002874 Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy Status COMPLETED Phase PHASE3
NCT00002855 Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Status COMPLETED Phase PHASE3
NCT00002848 Group Therapy Compared With Educational Materials in Patients With Prostate Cancer Status COMPLETED Phase NA
NCT00002775 Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00002760 Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE3